Regulatory requirements could be a main reason for physician dissatisfaction and increased burnout with electronic health records (EHRs), according to an Ideas and Opinions piece published May 8 in the Annals of Internal Medicine.

Japan’s Takeda Pharmaceuticals has announced it will acquire Shire, an Ireland-based drug company, for $62 billion, making Takeda one of the 10 largest pharma firms in the world.

Looking at the transition in leadership at 490 hospitals, a study found 82 facilities chose a new chief executive from among their existing C-suite leaders, while the vast majority—408 hospitals—went with an outside hire.

Sen. Lamar Alexander, R-Tennessee, has said he’s abandoning efforts to push a bipartisan bill meant to stabilize the Affordable Care Act (ACA) exchanges, putting the blame on Democrats’ resistance to making changes to the law. With no congressional action likely this far into an election year, exchange insurers are requesting some eye-popping hikes for 2019 premiums.

May 9 marks 100 days since Alex Azar was sworn in as the second HHS Secretary under President Donald Trump. Judging by what lobbyists, policy experts and Democrats said to Axios, he’s seen in a more positive light than his predecessor Tom Price, MD.

“For the first time, CMS is organizing and focusing our efforts to apply a rural lens to the vision and work of the agency,” CMS Administrator Seema Verma, MPH, said in a statement.

A team from the Wellcome Sanger Institute in the United Kingdom, the University of Otago in New Zealand and the Helmholtz Institute for RNA-based Infection Research in Germany has developed a machine learning tool capable of detecting strains of salmonella before they cause bloodstream infections. Findings were published May 8 in PLOS Genetics.

Change Healthcare has announced a collaboration with Adobe Systems and Microsoft to develop a more comprehensive patient engagement tool for providers to build patient relationships through technology.

The implementation of an early warning score communication bundle significantly decreased intensive care unit (ICU) admissions, according to a study published in the May 2018 issue of the American Journal of Critical Care.

The potential of genetic testing for chronic disease is substantial—and these possible positives are understood by many primary care providers (PCPs). Still, many feel unprepared to deal with patients at high risk for such conditions, while others questioned their ability to interpret genetic testing results.